12.03.2007 – 17:13

november AG

euro adhoc: november AG
other
Creditor's meetings approve insolvency plans Creditor’s meetings of november AG i.I., identif GmbH i.I. and directif GmbH i.I. approve the insolvency plans presented to them as essential requirement for the financial res

  Disclosure announcement transmitted by euro adhoc. The issuer is responsible
  for the content of this announcement.

12.03.2007

Erlangen, 12 March 2007. The creditor's meeting of  november AG i.l.
(ISIN DE0006762909), a biotech development- and investment-holding
located in Erlangen, Germany, has - in it's second session - approved
the insolvency plan presented to it. In subsequent separate meetings,
the creditors of identif GmbH i.I. and directif GmbH i.I. approved
the insolvency plan as well.  The approvals are essential
requirements for a successful financial restructuring. November AG
i.l. and Biomed-Group, Freiburg, Germany, as well as Dr. Claus Müller
intend to take further steps for a successful financial restructuring
.The success of the financial restructuring depends on the approvals
of the corporate bodies of november AG i.I. as well as on other
authorisations.

end of announcement                               euro adhoc 12.03.2007 16:39:14

Further inquiry note:

Marcus Weichert
Leitung PR/IR
Telefon: +49(0)9131 75088 868
E-Mail: weichert@november.de

Branche: Biotechnology
ISIN: DE0006762909
WKN: 676290
Index: CDAX, Technologie All Share, Prime All Share
Börsen: Frankfurter Wertpapierbörse / regulated dealing/prime
standard
Börse Berlin-Bremen / free trade
Baden-Württembergische Wertpapierbörse / free trade
Börse Düsseldorf / free trade
Niedersächsische Börse zu Hannover / free trade
Bayerische Börse / free trade